Press Release

TransEnterix to Showcase Senhance Surgical System at Society of American Gastrointestinal and Endoscopic Surgeons 2018 Annual Meeting

April 4, 2018 at 5:15 PM EDT

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Apr. 4, 2018--
TransEnterix, Inc. (NYSE American: TRXC), a medical device company that
is digitizing the interface between the surgeon and the patient to
improve minimally invasive surgery, will showcase the Senhance™ Surgical
System at the 16th World Congress of Endoscopic Surgery which is part of
the 2018 Annual Meeting of the Society of American Gastrointestinal and
Endoscopic Surgeons (SAGES). The meeting will be held April 11-14, 2018
in Seattle, Washington. Attendance at SAGES is expected to include over
2,500 general, colon & rectal, endoscopic, pediatric, bariatric, and
military surgeons as well as allied health professionals from across the
United States and around the globe.

The Senhance System will be featured in subooth #131 in the exhibition
hall and will be available for demonstrations.

About TransEnterix

TransEnterix is a medical device company that is digitizing the
interface between the surgeon and the patient to improve minimally
invasive surgery by addressing the clinical and economic challenges
associated with current laparoscopic and robotic options in today's
value-based healthcare environment. The Company is focused on the
commercialization of the Senhance™ Surgical System, which digitizes
laparoscopic minimally invasive surgery. The system allows for robotic
precision, haptic feedback, surgeon camera control via eye sensing and
improved ergonomics while offering responsible economics. The Senhance
Surgical System is available for sale in the US, the EU and select other
countries. For more information, visit www.transenterix.com.